|
CA1064396A
(en)
|
1975-02-18 |
1979-10-16 |
Myer L. Coval |
Fractional precipitation of gamma globulin with polyethylene glycol
|
|
US4075193A
(en)
|
1976-11-26 |
1978-02-21 |
Parke, Davis & Company |
Process for producing intravenous immune globulin
|
|
US4374763A
(en)
|
1979-09-17 |
1983-02-22 |
Morishita Pharmaceutical Co., Ltd. |
Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4499073A
(en)
|
1981-08-24 |
1985-02-12 |
Cutter Laboratories, Inc. |
Intravenously injectable immune serum globulin
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4597966A
(en)
|
1985-01-09 |
1986-07-01 |
Ortho Diagnostic Systems, Inc. |
Histidine stabilized immunoglobulin and method of preparation
|
|
US4966852A
(en)
|
1987-07-23 |
1990-10-30 |
Monsanto Company |
DNA clone of human tissue factor inhibitor
|
|
EP0303746B2
(en)
|
1987-08-21 |
1998-12-02 |
Mallinckrodt Group Inc. |
Stabilization of growth promoting hormones
|
|
US4877608A
(en)
|
1987-11-09 |
1989-10-31 |
Rorer Pharmaceutical Corporation |
Pharmaceutical plasma protein formulations in low ionic strength media
|
|
US5096885A
(en)
|
1988-04-15 |
1992-03-17 |
Genentech, Inc. |
Human growth hormone formulation
|
|
EP0417193B1
(en)
|
1988-05-27 |
1993-08-04 |
Centocor, Inc. |
Freeze-dried formulation for antibody products
|
|
JPH04504253A
(ja)
|
1989-03-27 |
1992-07-30 |
セントカー・インコーポレーテツド |
ＩｇＭ抗体の安定化のための配合物
|
|
US6969586B1
(en)
|
1989-05-16 |
2005-11-29 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
|
US5217954A
(en)
|
1990-04-04 |
1993-06-08 |
Scios Nova Inc. |
Formulations for stabilizing fibroblast growth factor
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
DK261490D0
(da)
|
1990-10-31 |
1990-10-31 |
Novo Nordisk As |
New pharmaceutical compound
|
|
JPH0565233A
(ja)
|
1991-03-08 |
1993-03-19 |
Mitsui Toatsu Chem Inc |
モノクローナル抗体含有凍結乾燥製剤
|
|
US6165467A
(en)
|
1991-07-20 |
2000-12-26 |
Yoshihide Hagiwara |
Stabilized human monoclonal antibody preparation
|
|
GB9122820D0
(en)
|
1991-10-28 |
1991-12-11 |
Wellcome Found |
Stabilised antibodies
|
|
EP0539975A1
(en)
|
1991-10-31 |
1993-05-05 |
Teijin Limited |
Method for immunological assay of free lipoprotein-associated coagulation inhibitor (LACI) and kit therefor
|
|
US5849700A
(en)
|
1991-12-20 |
1998-12-15 |
Novo Nordisk A/S |
Pharmaceutical formulation
|
|
DE4223132A1
(de)
|
1992-07-14 |
1994-01-20 |
Deutsche Aerospace |
Verfahren zur Schrittakt-Regeneration bei der Demodulation von digital modulierten Signalen und Anordnung zum Ausführen des Verfahrens
|
|
JPH06153985A
(ja)
|
1992-11-16 |
1994-06-03 |
Teijin Ltd |
モノクローナル抗体
|
|
DK0686045T3
(da)
|
1993-02-23 |
2001-03-05 |
Genentech Inc |
Stabilisering af med organisk opløsningsmiddel behandlede polypeptider med et hjælpestof
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
DE4344824C1
(de)
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
|
US5580856A
(en)
|
1994-07-15 |
1996-12-03 |
Prestrelski; Steven J. |
Formulation of a reconstituted protein, and method and kit for the production thereof
|
|
JPH0875736A
(ja)
|
1994-09-06 |
1996-03-22 |
Chemo Sero Therapeut Res Inst |
ヒト組織因子凝固系インヒビターの定量法
|
|
GB9418092D0
(en)
|
1994-09-08 |
1994-10-26 |
Red Cross Found Cent Lab Blood |
Organic compounds
|
|
US6111079A
(en)
|
1995-06-05 |
2000-08-29 |
Bionebraska, Inc. |
Lead binding polypeptides and nucleotides coding therefore
|
|
PT1516628E
(pt)
|
1995-07-27 |
2013-09-24 |
Genentech Inc |
Formulação de proteína liofilizada isotónica estável
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US5902582A
(en)
|
1995-09-05 |
1999-05-11 |
Chiron Corporation |
Use of TFPI inhibitor for treatment of cancer
|
|
US6686191B1
(en)
|
1995-09-22 |
2004-02-03 |
Bayer Healthcare Llc |
Preparation of virally inactivated intravenously injectable immune serum globulin
|
|
US7368111B2
(en)
*
|
1995-10-06 |
2008-05-06 |
Cambridge Antibody Technology Limited |
Human antibodies specific for TGFβ2
|
|
JP3681206B2
(ja)
*
|
1995-12-26 |
2005-08-10 |
株式会社三菱化学ヤトロン |
抗ファクターＸａ・ティシュファクターパスウェイインヒビター複合体モノクローナル抗体及びその使用
|
|
US5770700A
(en)
|
1996-01-25 |
1998-06-23 |
Genetics Institute, Inc. |
Liquid factor IX formulations
|
|
ES2208884T3
(es)
|
1996-01-25 |
2004-06-16 |
Schering Aktiengesellschaft |
Soluciones mejoradas de agentes de contraste para la administracion intravasal.
|
|
KR100236393B1
(ko)
|
1996-02-02 |
1999-12-15 |
나까니시 히로유끼 |
사람성장호르몬을 함유하는 의약제제
|
|
TW518219B
(en)
|
1996-04-26 |
2003-01-21 |
Chugai Pharmaceutical Co Ltd |
Erythropoietin solution preparation
|
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
|
US20040052799A1
(en)
|
1996-11-15 |
2004-03-18 |
Astra Aktiebolag |
Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
US6593291B1
(en)
|
1997-02-06 |
2003-07-15 |
Entremed, Inc. |
Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
|
|
WO1998042850A1
(en)
|
1997-03-26 |
1998-10-01 |
Rpms Technology Limited |
Anticoagulant fusion protein anchored to cell membrane
|
|
US5994511A
(en)
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
|
WO1999003496A1
(en)
|
1997-07-21 |
1999-01-28 |
The University Of North Carolina At Chapel Hill |
Factor ix antihemophilic factor with increased clotting activity
|
|
US6617156B1
(en)
|
1997-08-15 |
2003-09-09 |
Lynn A. Doucette-Stamm |
Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
|
|
WO1999011091A1
(de)
|
1997-08-21 |
1999-03-04 |
Siemens Aktiengesellschaft |
Verfahren zum übertragen von nutzdaten, die unterschiedlichen anwendungen zuordenbar sind
|
|
US6551795B1
(en)
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
|
JP2002505871A
(ja)
|
1998-03-12 |
2002-02-26 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
３１個のヒト分泌タンパク質
|
|
GB9820525D0
(en)
|
1998-09-21 |
1998-11-11 |
Allergy Therapeutics Ltd |
Formulation
|
|
US6818749B1
(en)
|
1998-10-31 |
2004-11-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Variants of humanized anti carcinoma monoclonal antibody cc49
|
|
JP2000247903A
(ja)
|
1999-03-01 |
2000-09-12 |
Chugai Pharmaceut Co Ltd |
長期安定化製剤
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
US20090087878A9
(en)
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
US20100293669A2
(en)
|
1999-05-06 |
2010-11-18 |
Jingdong Liu |
Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
ATE464062T1
(de)
|
1999-10-04 |
2010-04-15 |
Novartis Vaccines & Diagnostic |
Stabilisierte flüssige pharmazeutische zusammensetzung enthaltend tfpi
|
|
US20050208558A1
(en)
|
1999-10-19 |
2005-09-22 |
Applera Corporation |
Detection kits, such as nucleic acid arrays, for detecting the expression or 10,000 or more Drosophila genes and uses thereof
|
|
JP4623825B2
(ja)
|
1999-12-16 |
2011-02-02 |
協和発酵バイオ株式会社 |
新規ポリヌクレオチド
|
|
US20020160934A1
(en)
|
2000-01-14 |
2002-10-31 |
Julie Broadus |
Nucleic acid sequences from Drosophila melanogaster that encode proteins essential for larval viability and uses thereof
|
|
US20030232054A1
(en)
|
2000-01-25 |
2003-12-18 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
|
AU2001236005A1
(en)
|
2000-02-29 |
2001-09-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preparations stabilized over long time
|
|
EP1272211B1
(en)
|
2000-04-07 |
2007-06-06 |
Signal Coordinating Therapy, Inc. |
Methods and compositions for treating neoplasms
|
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
US7834146B2
(en)
|
2000-05-08 |
2010-11-16 |
Monsanto Technology Llc |
Recombinant polypeptides associated with plants
|
|
US20040181830A1
(en)
|
2001-05-07 |
2004-09-16 |
Kovalic David K. |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
US7015194B2
(en)
*
|
2000-05-10 |
2006-03-21 |
Novo Nordisk A/S |
Pharmaceutical composition comprising factor VIIa and anti-TFPI
|
|
US20020082206A1
(en)
|
2000-05-30 |
2002-06-27 |
Leach Martin D. |
Novel polynucleotides from atherogenic cells and polypeptides encoded thereby
|
|
DE60143798D1
(de)
|
2000-06-16 |
2011-02-17 |
Cambridge Antibody Tech |
Immunspezifisch bindende antikörper gegen blys
|
|
WO2002011753A1
(en)
|
2000-08-04 |
2002-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
|
US8632778B2
(en)
|
2000-08-11 |
2014-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilized anti-interleukin-6 antibody-containing preparations
|
|
KR20030027077A
(ko)
|
2000-09-01 |
2003-04-03 |
쥬가이 세이야쿠 가부시키가이샤 |
장기 안정화 용액 제제
|
|
PT1324776E
(pt)
|
2000-10-12 |
2009-12-23 |
Genentech Inc |
Formulações de proteína concentradas de viscosidade reduzida
|
|
US7214786B2
(en)
|
2000-12-14 |
2007-05-08 |
Kovalic David K |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
GB0101879D0
(en)
|
2001-01-24 |
2001-03-07 |
Enzyme Res Lab Ltd |
Anticoagulants and their uses
|
|
WO2002094867A2
(fr)
|
2001-02-07 |
2002-11-28 |
Institut Pasteur |
Sequence du genome de photorhabdus luminescens souche tto1 et utilisations
|
|
GB0103424D0
(en)
|
2001-02-12 |
2001-03-28 |
Chiron Spa |
Gonococcus proteins
|
|
US7667004B2
(en)
*
|
2001-04-17 |
2010-02-23 |
Abmaxis, Inc. |
Humanized antibodies against vascular endothelial growth factor
|
|
US6891085B2
(en)
|
2001-04-20 |
2005-05-10 |
Pioneer Hi-Bred International, Inc. |
Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant
|
|
EP1390507A2
(en)
|
2001-05-21 |
2004-02-25 |
Ecopia Biosciences Inc. |
Genes and proteins involved in the biosynthesis of enediyne ring structures
|
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
|
WO2003009817A2
(en)
|
2001-07-25 |
2003-02-06 |
Protein Design Labs, Inc. |
Stable lyophilized pharmaceutical formulation of igg antibodies
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
KR20050036852A
(ko)
*
|
2001-10-15 |
2005-04-20 |
기린 비루 가부시키가이샤 |
항-ｈｌａ-ｄｒ 항체
|
|
CN1604788B
(zh)
|
2001-10-16 |
2013-04-17 |
里克斯金蒂克斯公司 |
高浓度蛋白制剂及其制备方法
|
|
US20040029129A1
(en)
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
|
AU2002363253A1
(en)
|
2001-11-01 |
2003-05-12 |
Gpc Biotech Inc. |
Endothelial-cell binding peptides for diagnosis and therapy
|
|
IL161677A0
(en)
|
2001-11-08 |
2004-09-27 |
Protein Design Labs |
Stable liquid pharmaceutical formulation of igg antibodies
|
|
CA2473883A1
(en)
|
2001-11-29 |
2003-06-12 |
Wyeth Holdings Corporation |
Alloiococcus otitidis open reading frames (orfs) encoding polypeptide antigens, immunogenic compositions and uses thereof
|
|
US20030138416A1
(en)
|
2001-12-03 |
2003-07-24 |
Jesper Lau |
Use of glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
|
|
US20050108791A1
(en)
|
2001-12-04 |
2005-05-19 |
Edgerton Michael D. |
Transgenic plants with improved phenotypes
|
|
WO2003062375A2
(en)
|
2001-12-19 |
2003-07-31 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
|
AU2003225535A1
(en)
|
2002-01-31 |
2003-09-02 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cancer
|
|
WO2003068260A1
(fr)
|
2002-02-14 |
2003-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Produits pharmaceutiques en solution contenant des anticorps
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
PL215168B1
(pl)
|
2002-02-27 |
2013-10-31 |
Immunex Corp |
Formulacja polipeptydowa
|
|
WO2003076575A2
(en)
|
2002-03-04 |
2003-09-18 |
Fidelity Systems, Inc., Et Al. |
The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
|
|
US7074559B2
(en)
|
2002-03-06 |
2006-07-11 |
Refents of the University of Minnesota |
Mycobacterial diagnostics
|
|
WO2005123131A2
(en)
|
2004-06-14 |
2005-12-29 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
|
IL149820A0
(en)
|
2002-05-23 |
2002-11-10 |
Curetech Ltd |
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
|
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
US20040022792A1
(en)
|
2002-06-17 |
2004-02-05 |
Ralph Klinke |
Method of stabilizing proteins at low pH
|
|
CA2490423A1
(en)
|
2002-06-21 |
2003-12-31 |
Biogen Idec Inc. |
Buffered formulations for concentrating antibodies and methods of use thereof
|
|
EP1539235A2
(en)
|
2002-07-01 |
2005-06-15 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to reg iv
|
|
US20050276823A1
(en)
|
2002-07-12 |
2005-12-15 |
Cini John K |
Methods and compositions for preventing oxidative degradation of proteins
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
DE10239073A1
(de)
|
2002-08-26 |
2004-03-11 |
Basf Ag |
Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien
|
|
US7252822B2
(en)
|
2002-10-08 |
2007-08-07 |
Rinat Neuroscience Corp. |
Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist
|
|
KR100542401B1
(ko)
|
2002-10-23 |
2006-01-11 |
한국전자통신연구원 |
인터넷 차별 서비스 망에서의 연결 수락 제어방법
|
|
MXPA05005925A
(es)
|
2002-12-02 |
2006-02-08 |
Abgenix Inc |
Anticuerpos dirigidos a la fosfolipasa a2 y sus usos.
|
|
AU2003293543A1
(en)
|
2002-12-13 |
2004-07-09 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
|
CN102746399B
(zh)
|
2002-12-24 |
2016-03-02 |
里纳特神经系统学公司 |
抗ngf抗体及其使用方法
|
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
|
CA2889013C
(en)
|
2003-03-07 |
2018-07-17 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
US20050158303A1
(en)
|
2003-04-04 |
2005-07-21 |
Genentech, Inc. |
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
|
HRP20050934B1
(hr)
|
2003-04-04 |
2014-09-26 |
Genentech, Inc. |
Formulacije s visokom koncentracijom antitijela i proteina
|
|
CN1816351A
(zh)
*
|
2003-06-27 |
2006-08-09 |
艾伯吉尼斯公司 |
针对表皮生长因子受体的缺失突变体的抗体及其使用
|
|
CN1849138B
(zh)
|
2003-07-15 |
2011-11-30 |
安姆根有限公司 |
作为选择性ngf途径抑制剂的人抗ngf中和抗体
|
|
MXPA06000508A
(es)
|
2003-07-18 |
2006-04-05 |
Amgen Inc |
Agentes de union especifica al factor del crecimiento de los hepatocitos.
|
|
US7871610B2
(en)
|
2003-08-12 |
2011-01-18 |
Dyax Corp. |
Antibodies to Tie1 ectodomain
|
|
US20060107345A1
(en)
|
2003-09-30 |
2006-05-18 |
Nickolai Alexandrov |
Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
|
|
SI1698640T2
(sl)
|
2003-10-01 |
2019-08-30 |
Kyowa Hakko Kirin Co., Ltd. |
Postopek za stabiliziranje protitelesa in stabiliziran pripravek protitelesa tipa raztopina
|
|
CA2445743A1
(en)
|
2003-10-08 |
2005-04-08 |
The University Of British Columbia |
Methods for modulating neuronal responses
|
|
EP1532983A1
(en)
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
|
US7855274B2
(en)
|
2003-12-03 |
2010-12-21 |
University Of Rochester |
Recombinant factor VIII having increased specific activity
|
|
US20070184050A1
(en)
|
2003-12-25 |
2007-08-09 |
Kirin Beer Kabushiki Kaisha |
Stable water-based medicinal preparation containing antibody
|
|
EP3018140A3
(en)
|
2004-01-09 |
2016-08-17 |
Basf Se |
Inactivation of glutamylpolypeptide synthesis in bacillus
|
|
US20060041961A1
(en)
|
2004-03-25 |
2006-02-23 |
Abad Mark S |
Genes and uses for pant improvement
|
|
NZ580607A
(en)
|
2004-05-27 |
2011-05-27 |
Crucell Holland Bv |
Binding molecules capable of neutralizing rabies virus and uses thereof
|
|
WO2006017173A1
(en)
|
2004-07-10 |
2006-02-16 |
Alexion Pharmaceuticals, Inc. |
Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby
|
|
US20080008719A1
(en)
|
2004-07-10 |
2008-01-10 |
Bowdish Katherine S |
Methods and compositions for the treatment of prostate cancer
|
|
US20060075522A1
(en)
|
2004-07-31 |
2006-04-06 |
Jaclyn Cleveland |
Genes and uses for plant improvement
|
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
US20080148432A1
(en)
|
2005-12-21 |
2008-06-19 |
Mark Scott Abad |
Transgenic plants with enhanced agronomic traits
|
|
WO2006068953A2
(en)
|
2004-12-21 |
2006-06-29 |
Astrazeneca Ab |
Antibodies directed to angiopoietin-2 and uses thereof
|
|
WO2006081139A2
(en)
|
2005-01-26 |
2006-08-03 |
Abgenix, Inc. |
Antibodies against interleukin-1 beta
|
|
EA013118B1
(ru)
|
2005-01-27 |
2010-02-26 |
Новиммун С.А. |
Антитела против интерферона-гамма и способы их применения
|
|
KR20070107079A
(ko)
|
2005-01-28 |
2007-11-06 |
와이어쓰 |
안정화된 액체 폴리펩타이드 제형
|
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
EP3520815B1
(en)
|
2005-02-08 |
2021-11-17 |
Genzyme Corporation |
Antibodies to tgfbeta
|
|
US8088976B2
(en)
|
2005-02-24 |
2012-01-03 |
Monsanto Technology Llc |
Methods for genetic control of plant pest infestation and compositions thereof
|
|
CA2598792A1
(en)
|
2005-03-02 |
2006-09-08 |
Metanomics Gmbh |
Process for the production of fine chemicals
|
|
DE602006021290D1
(de)
|
2005-03-04 |
2011-05-26 |
Univ Illinois |
Modulator von coagulationskaskaden und fibrinolytischen kaskaden
|
|
AR054428A1
(es)
|
2005-03-08 |
2007-06-27 |
Pharmacia & Upjohn Co Llc |
Composiciones de anticuerpos anti factor estimulante de colonia de macrofagos (anti-m-csf) que tienen menores niveles de endotoxina
|
|
WO2006096461A2
(en)
|
2005-03-08 |
2006-09-14 |
Pharmacia & Upjohn Company Llc |
Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
|
|
CN101166763B
(zh)
|
2005-04-18 |
2012-09-19 |
伊达研究和发展有限公司 |
稳定的抗乙肝病毒(hbv)抗体配制剂
|
|
US7889636B2
(en)
|
2005-05-24 |
2011-02-15 |
Cisco Technology, Inc. |
System and method for implementing a mid-call policy in a RSVP environment
|
|
GB2426887B
(en)
|
2005-06-04 |
2009-01-07 |
Ibm |
Client responsibilities in messaging systems
|
|
DK1899462T3
(da)
|
2005-07-02 |
2011-06-06 |
Arecor Ltd |
Stabile vandige systemer omfattende proteiner
|
|
JP2009503105A
(ja)
|
2005-08-03 |
2009-01-29 |
イミュノジェン・インコーポレーテッド |
免疫複合体製剤
|
|
AU2006295340B2
(en)
|
2005-08-05 |
2010-11-11 |
Amgen Inc. |
Stable aqueous protein or antibody pharmaceutical formulations and their preparation
|
|
US20070086433A1
(en)
|
2005-10-19 |
2007-04-19 |
Cunetto Philip C |
Methods and apparatus for allocating shared communication resources to outdial communication services
|
|
BRPI0618850A2
(pt)
|
2005-11-21 |
2011-09-13 |
Sanofi Pasteur Ltd |
formulações de estabilização para vìrus recombinantes
|
|
EP1957540B1
(en)
|
2005-12-02 |
2012-06-13 |
Genentech, Inc. |
Binding polypeptides and uses thereof
|
|
US7669228B2
(en)
|
2005-12-27 |
2010-02-23 |
Cisco Technology, Inc. |
System and method for changing network behavior based on presence information
|
|
EP1977763A4
(en)
|
2005-12-28 |
2010-06-02 |
Chugai Pharmaceutical Co Ltd |
ANTIBODY-CONTAINING STABILIZING PREPARATION
|
|
AU2007212147A1
(en)
|
2006-02-03 |
2007-08-16 |
Medimmune, Llc |
Protein formulations
|
|
DE102006005094A1
(de)
|
2006-02-04 |
2007-08-09 |
Degussa Gmbh |
Titandioxid und Polycarboxylatether enthaltende Dispersion
|
|
WO2007112054A2
(en)
|
2006-03-23 |
2007-10-04 |
Sea Lane Biotechnologies, Llc |
Facilitation of translocation of molecules through the gastrointestinal tract
|
|
EP2044118A2
(en)
|
2006-06-13 |
2009-04-08 |
Zymogenetics, Inc. |
Il-17 and il-23 antagonists and methods of using the same
|
|
EP2029163A4
(en)
|
2006-06-14 |
2010-08-11 |
Imclone Llc |
LYOPHILIZED FORMULATIONS OF ANTI-EGFR ANTIBODIES
|
|
AU2007276294B2
(en)
|
2006-06-30 |
2012-11-29 |
Novo Nordisk A/S |
Anti-NKG2A antibodies and uses thereof
|
|
US8355333B2
(en)
|
2006-08-31 |
2013-01-15 |
Ciena Corporation |
Methods and systems for session initiation protocol control of network equipment
|
|
BRPI0719250A2
(pt)
|
2006-10-12 |
2015-06-16 |
Wyeth Corp |
Métodos e composições com opalescência reduzida.
|
|
BRPI0721097A2
(pt)
|
2006-12-11 |
2014-07-01 |
Hoffmann La Roche |
Formulação parenteral de anticorpo abeta
|
|
AU2008232903B9
(en)
|
2007-03-30 |
2013-09-05 |
Medimmune Llc |
Antibodies with decreased deamidation profiles
|
|
GB0707938D0
(en)
|
2007-04-25 |
2007-05-30 |
Univ Strathclyde |
Precipitation stabilising compositions
|
|
ES2707815T3
(es)
|
2007-06-14 |
2019-04-05 |
Biogen Ma Inc |
Formulaciones de anticuerpo natalizumab
|
|
UA107557C2
(xx)
|
2007-07-06 |
2015-01-26 |
|
Композиція антитіла офатумумабу
|
|
ES2566963T3
(es)
*
|
2007-11-21 |
2016-04-18 |
Oregon Health & Science University |
Anticuerpos monoclonales anti-factor XI y métodos de uso de los mismos
|
|
EP2225275A4
(en)
|
2007-11-28 |
2013-04-03 |
Medimmune Llc |
PROTEIN FORMULATION
|
|
JP5591712B2
(ja)
|
2007-12-14 |
2014-09-17 |
ノボ・ノルデイスク・エー／エス |
ヒトｎｋｇ２ｄに対する抗体とその使用
|
|
DK2234600T3
(da)
|
2007-12-21 |
2014-09-08 |
Hoffmann La Roche |
Antistofformulering
|
|
US20110014203A1
(en)
|
2007-12-28 |
2011-01-20 |
Fredrik Nilsson |
Formulation
|
|
EP2254911B1
(en)
|
2008-02-20 |
2015-11-25 |
Novo Nordisk A/S |
Humanized anti-c5ar antibodies
|
|
WO2009120684A1
(en)
|
2008-03-25 |
2009-10-01 |
Medimmune, Llc |
Antibody formulation
|
|
MX2010013565A
(es)
|
2008-06-30 |
2011-01-14 |
Novo Nordisk As |
Anticuerpos de interleucina-20 anti-humanos.
|
|
UA112050C2
(uk)
|
2008-08-04 |
2016-07-25 |
БАЄР ХЕЛСКЕР ЛЛСі |
Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
|
|
TR201802935T4
(tr)
|
2008-09-19 |
2018-03-21 |
Pfizer |
Stabil sıvı antikor formülasyonu.
|
|
AU2009319856A1
(en)
|
2008-11-28 |
2010-06-03 |
Abbvie Inc. |
Stable antibody compositions and methods for stabilizing same
|
|
EP2196476A1
(en)
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
|
LT2379096T
(lt)
|
2008-12-19 |
2019-12-27 |
Baxalta GmbH |
Tfpi inhibitoriai ir vartojimo būdai
|
|
EP2379600B2
(en)
|
2008-12-22 |
2020-10-14 |
Novo Nordisk A/S |
Antibodies against tissue factor pathway inhibitor
|
|
CN102300876A
(zh)
|
2008-12-22 |
2011-12-28 |
诺沃—诺迪斯克有限公司 |
针对组织因子途径抑制剂(tfpi)的抗体
|
|
AU2010221156A1
(en)
|
2009-03-06 |
2011-09-22 |
Genentech, Inc. |
Antibody formulation
|
|
CN102695499A
(zh)
|
2009-06-18 |
2012-09-26 |
惠氏有限责任公司 |
小模块免疫药物的冻干制剂
|
|
PT2473528E
(pt)
|
2009-09-03 |
2015-03-04 |
Ablynx NV |
Formulações estáveis de polipéptidos e seus usos
|
|
EP2332995A1
(en)
|
2009-12-10 |
2011-06-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neutralizing prolactin receptor antibodies and their therapeutic use
|
|
CN107496917B
(zh)
|
2010-02-26 |
2021-06-11 |
诺沃—诺迪斯克有限公司 |
包含稳定抗体的组合物
|
|
SG183443A1
(en)
*
|
2010-03-01 |
2012-09-27 |
Bayer Healthcare Llc |
Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
|
|
EP2547355B1
(en)
|
2010-03-19 |
2017-01-11 |
Baxalta GmbH |
Tfpi inhibitors and methods of use
|
|
MX2012013586A
(es)
|
2010-05-28 |
2013-01-24 |
Novo Nordisk As |
Composiciones multi-dosis estables que comprenden un anticuerpo y un conservante.
|
|
EP2673364A1
(en)
|
2011-02-11 |
2013-12-18 |
Baxter International Inc |
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
|
|
JP6170903B2
(ja)
|
2011-04-01 |
2017-07-26 |
バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ |
組織因子経路インヒビター（ｔｆｐｉ）に対するモノクローナル抗体
|
|
AU2013235567A1
(en)
|
2012-03-22 |
2014-10-09 |
Baxalta GmbH |
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
|
|
US9592297B2
(en)
|
2012-08-31 |
2017-03-14 |
Bayer Healthcare Llc |
Antibody and protein formulations
|
|
US8613919B1
(en)
|
2012-08-31 |
2013-12-24 |
Bayer Healthcare, Llc |
High concentration antibody and protein formulations
|
|
CN113788897A
(zh)
|
2013-03-15 |
2021-12-14 |
拜尔健康护理有限责任公司 |
改善药代动力学的具有跨pH范围差异结合的抗TFPI抗体变体
|
|
CN107428838B
(zh)
|
2015-02-25 |
2021-01-01 |
财团法人牧岩生命科学研究所 |
结合tfpi的新型抗体以及包含所述抗体的组合物
|
|
KR20230074843A
(ko)
|
2015-08-19 |
2023-05-31 |
화이자 인코포레이티드 |
조직 인자 경로 억제제 항체 및 그의 용도
|